Correlative Studies of Angiogenesis in Breast Cancer

Hayes, Daniel F.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 7U01CA064057-04
• Application #: 2390833
• Study Section: Special Emphasis Panel (SRC (80))
• Project Start: 1994-06-01
• Project End: 1998-03-31
• Budget Start: 1997-02-01
• Budget End: 1997-03-31
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: Georgetown University
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 049515844
• City: Washington
• State: DC
• Country: United States
• Zip Code: 20057

Publications

Akewanlop, C; Watanabe, M; Singh, B et al. (2001) Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody. Cancer Res 61:4061-5

Watanabe, M; Wallace, P K; Keler, T et al. (1999) Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210. Breast Cancer Res Treat 53:199-207

Yamauchi, H; O'Neill, A; Gelman, R et al. (1997) Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein. J Clin Oncol 15:2518-25

Hayes, D F; Bast, R C; Desch, C E et al. (1996) Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88:1456-66

Gimmi, C D; Morrison, B W; Mainprice, B A et al. (1996) Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat Med 2:1367-70